|
|
left right pattern formation
|
GO:0060972 |
23 |
0.999
|
|
|
|
intraciliary retrograde transport
|
GO:0035721 |
3 |
0.992
|
|
|
|
embryonic heart tube left right pattern formation
|
GO:0060971 |
5 |
0.980
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.960
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.893
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.862
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.859
|
|
|
|
sperm ejaculation
|
GO:0042713 |
1 |
0.847
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.834
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.809
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.802
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.763
|
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
3 |
0.679
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.673
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.645
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.637
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.493
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.440
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.434
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.434
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.415
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.374
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.363
|
|
|
|
cilium movement
|
GO:0003341 |
28 |
0.357
|
|
|
|
nonmotile primary cilium assembly
|
GO:0035058 |
8 |
0.332
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.301
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.300
|
|
|
|
intraciliary transport
|
GO:0042073 |
9 |
0.293
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.271
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.264
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.252
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.247
|
|
|
|
prechordal plate formation
|
GO:0021501 |
1 |
0.237
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.221
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.218
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.214
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.211
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.205
|
|
|
|
insemination
|
GO:0007320 |
6 |
0.199
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
25 |
0.197
|
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
1 |
0.197
|
|
|
|
detection of nodal flow
|
GO:0003127 |
2 |
0.194
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.189
|
|
|
|
smoothened signaling pathway involved in dorsal ventral neural tube patterning
|
GO:0060831 |
12 |
0.188
|
|
|
|
sensory perception of sour taste
|
GO:0050915 |
2 |
0.175
|
|
|
|
floor plate morphogenesis
|
GO:0033505 |
3 |
0.161
|
|
|
|
regulation of inositol 1 4 5 trisphosphate sensitive calcium release channel activity
|
GO:0031585 |
2 |
0.159
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.150
|
|
|
|
left right axis specification
|
GO:0070986 |
13 |
0.148
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.147
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.147
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.146
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.145
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.144
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.142
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.140
|
|
|
|
cellular response to acidic ph
|
GO:0071468 |
4 |
0.139
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.138
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.135
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.134
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.133
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.130
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.129
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.128
|
Human |
|
|
muscle system process
|
GO:0003012 |
141 |
0.124
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.123
|
|
|
|
ventricular system development
|
GO:0021591 |
27 |
0.116
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.116
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.115
|
|
|
|
negative regulation of cation channel activity
|
GO:2001258 |
1 |
0.114
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.112
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.109
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.109
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.109
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.109
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.102
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.101
|
|
|
|
negative regulation of calcium ion transmembrane transporter activity
|
GO:1901020 |
1 |
0.100
|
|
|
|
response to fluid shear stress
|
GO:0034405 |
7 |
0.100
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.100
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.098
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.093
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.092
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.091
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.089
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.089
|
|
|
|
proximal convoluted tubule development
|
GO:0072019 |
1 |
0.087
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.087
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.085
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.084
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
18 |
0.083
|
|
|
|
protein localization to nonmotile primary cilium
|
GO:0097499 |
1 |
0.081
|
|
|
|
detection of chemical stimulus involved in sensory perception
|
GO:0050907 |
10 |
0.080
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.080
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.080
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.080
|
|
|
|
left lung morphogenesis
|
GO:0060460 |
3 |
0.079
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.079
|
|
|
|
negative regulation of ryanodine sensitive calcium release channel activity
|
GO:0060315 |
1 |
0.077
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.075
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.075
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.075
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.073
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.072
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.071
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.070
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.069
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.069
|
Human |
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.069
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.069
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.068
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.068
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.066
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.065
|
|
|
|
venous blood vessel development
|
GO:0060841 |
13 |
0.064
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.064
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.064
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.063
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.063
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.063
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.059
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.059
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.059
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.058
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.057
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.057
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.056
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.056
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.055
|
|
|
|
axial mesodermal cell fate specification
|
GO:0048327 |
1 |
0.055
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.055
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.055
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.054
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.054
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.054
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.054
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.054
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.053
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.053
|
|
|
|
regulation of mitotic spindle organization
|
GO:0060236 |
2 |
0.052
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.052
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.052
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.052
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.051
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.051
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.051
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.051
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.051
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.051
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.050
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.050
|
|
|
|
adrenal cortex formation
|
GO:0035802 |
2 |
0.050
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.047
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.047
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.046
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.046
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.046
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.046
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.046
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.045
|
|
|
|
negative regulation of calcium ion transmembrane transport
|
GO:1903170 |
1 |
0.045
|
|
|
|
regulation of spindle organization
|
GO:0090224 |
2 |
0.043
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.043
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.043
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.043
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.042
|
|
|
|
metanephric collecting duct development
|
GO:0072205 |
7 |
0.041
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.041
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.041
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.041
|
|
|
|
positive regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035360 |
2 |
0.041
|
|
|
|
calcium ion dependent exocytosis
|
GO:0017156 |
35 |
0.041
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
10 |
0.040
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.040
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.040
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.040
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.040
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.040
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.039
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.039
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.038
|
Worm |
|
|
mating
|
GO:0007618 |
27 |
0.038
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.038
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.038
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.037
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.037
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.037
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.037
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.036
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.036
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.036
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.036
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.036
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.035
|
|
|
|
signal transduction downstream of smoothened
|
GO:0007227 |
4 |
0.034
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.034
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.034
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.034
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.034
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.034
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.034
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.034
|
|
|
|
metanephric part of ureteric bud development
|
GO:0035502 |
2 |
0.034
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.034
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.033
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.033
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.033
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.033
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.032
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.032
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.032
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.032
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.031
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.031
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.031
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.031
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.030
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.030
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.030
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.030
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.030
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.029
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.029
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.029
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.029
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.028
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.028
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.028
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.028
|
|
|
|
determination of digestive tract left right asymmetry
|
GO:0071907 |
1 |
0.028
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.028
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.028
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.028
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.028
|
Human |
|
|
forebrain development
|
GO:0030900 |
302 |
0.028
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.028
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.027
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.027
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.027
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.027
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.027
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.027
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.027
|
|
|
|
hypothalamus cell migration
|
GO:0021855 |
5 |
0.027
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.026
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
44 |
0.026
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.026
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.026
|
|
|
|
negative regulation of protein localization to nucleus
|
GO:1900181 |
23 |
0.026
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.026
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.026
|
|
|
|
acrosome reaction
|
GO:0007340 |
19 |
0.026
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.026
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.026
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.026
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.026
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.025
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.025
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.025
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.025
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.024
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
Mouse |
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.024
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.024
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.023
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.023
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.023
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.023
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.023
|
|
|
|
positive regulation of activin receptor signaling pathway
|
GO:0032927 |
3 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.023
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.023
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.023
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.023
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.023
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.023
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.023
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.022
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.022
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.022
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.022
|
|
|
|
regulation of calcium ion dependent exocytosis
|
GO:0017158 |
16 |
0.022
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.022
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.022
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.022
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.022
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.022
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.022
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.022
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.022
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.022
|
|
|
|
positive regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045737 |
6 |
0.022
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.021
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.021
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.021
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.021
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.021
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.021
|
|
|
|
renal system vasculature morphogenesis
|
GO:0061438 |
7 |
0.021
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.021
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.021
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.021
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.021
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.021
|
|
|
|
floor plate formation
|
GO:0021508 |
2 |
0.021
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.021
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.021
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.021
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.020
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.020
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.020
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.020
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.020
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.020
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.020
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.020
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.020
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.020
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.020
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.020
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.019
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.019
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.019
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.019
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.019
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.019
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.019
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.018
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.018
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.018
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.018
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.018
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.018
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.018
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.017
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.017
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.017
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.017
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.017
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.017
|
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
7 |
0.017
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.017
|
|
|
|
nodal signaling pathway
|
GO:0038092 |
10 |
0.017
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.017
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.017
|
|
|
|
tongue muscle cell differentiation
|
GO:0035981 |
2 |
0.017
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0097201 |
1 |
0.017
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.017
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.017
|
|
|
|
epithelial cilium movement
|
GO:0003351 |
12 |
0.016
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.016
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.016
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.016
|
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.016
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.016
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.016
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.016
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.016
|
Human |
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.015
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.015
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.015
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.015
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.015
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.015
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.015
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.015
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.015
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.015
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.015
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.015
|
|
|
|
response to ph
|
GO:0009268 |
14 |
0.015
|
|
|
|
negative regulation of transcription factor import into nucleus
|
GO:0042992 |
13 |
0.015
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
24 |
0.015
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.015
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.015
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.015
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.015
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.015
|
|
|
|
nephrogenic mesenchyme morphogenesis
|
GO:0072134 |
2 |
0.015
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.015
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.015
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.015
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.014
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.014
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.014
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.014
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.014
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.014
|
|
|
|
renal artery morphogenesis
|
GO:0061441 |
1 |
0.014
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.014
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.014
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.014
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.014
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.014
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.014
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.014
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.014
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.014
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.014
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.014
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.014
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.014
|
|
|
|
positive regulation of male gonad development
|
GO:2000020 |
6 |
0.014
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.014
|
|
|
|
smoothened signaling pathway involved in ventral spinal cord patterning
|
GO:0021910 |
7 |
0.014
|
|
|
|
proximal tubule development
|
GO:0072014 |
5 |
0.014
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.014
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.014
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.014
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.014
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.014
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.014
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.014
|
|
|
|
transcription factor import into nucleus
|
GO:0042991 |
26 |
0.013
|
|
|
|
cellular response to osmotic stress
|
GO:0071470 |
7 |
0.013
|
|
|
|
maintenance of protein location in cell
|
GO:0032507 |
20 |
0.013
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.013
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.013
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.013
|
|
|
|
adrenal cortex development
|
GO:0035801 |
2 |
0.013
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.013
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.013
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.013
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.013
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.013
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.013
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.013
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.013
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.013
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.013
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.013
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.013
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.013
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.013
|
|
|
|
ventral midline development
|
GO:0007418 |
4 |
0.013
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.013
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.013
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.013
|
|
|
|
positive regulation of rab gtpase activity
|
GO:0032851 |
7 |
0.013
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.013
|
|
|
|
positive regulation of posttranscriptional gene silencing
|
GO:0060148 |
1 |
0.013
|
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.013
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.013
|
|
|
|
penile erection
|
GO:0043084 |
2 |
0.013
|
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.013
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.012
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.012
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.012
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.012
|
Mouse |
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.012
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.012
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.012
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.012
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.012
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.012
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.012
|
|
|
|
lymph vessel morphogenesis
|
GO:0036303 |
11 |
0.012
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.012
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.012
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.012
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.012
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
15 |
0.012
|
|
